We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.42%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$11.6B
AUM Growth
+$243M
(+2.1%)
Cap. Flow
-$770M
Cap. Flow
% of AUM
-6.61%
Top 10 Holdings %
Top 10 Hldgs %
17.24%
Holding
303
New
50
Increased
66
Reduced
133
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$102M |
| 2 |
S&P Global
SPGI
|
+$82.9M |
| 3 |
Intercontinental Exchange
ICE
|
+$72.4M |
| 4 |
Nike
NKE
|
+$55.5M |
| 5 |
Avery Dennison
AVY
|
+$49.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$95.4M |
| 2 |
TJX Companies
TJX
|
+$94.8M |
| 3 |
Chubb
CB
|
+$87.2M |
| 4 |
Intel
INTC
|
+$80.1M |
| 5 |
Union Pacific
UNP
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 17.63% |
| 3 | Consumer Discretionary | 13.42% |
| 4 | Industrials | 12.91% |
| 5 | Communication Services | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Genesco
GCO
$425M
| $12.5M | 0.11% |
224,802
+59,232
| +36% | +$3.53M |
|
202
NXP Semiconductors
NXPI
$57.8B
| $12.3M | 0.11% |
+119,066
| New | +$12M |
|
203
Marten Transport
MRTN
$1.21B
| $11.9M | 0.1% |
1,265,223
+38,838
| +3% | +$367K |
|
204
Euronet Worldwide
EEFT
$2.72B
| $11M | 0.09% |
128,060
-131,615
| -51% | -$10.3M |
|
|
CHCT
205
Community Healthcare Trust
CHCT
$523M
| $10.9M | 0.09% |
455,027
-55,803
| -11% | -$1.28M |
|
|
IRBT
206
DELISTED
iRobot
IRBT
| $10.7M | 0.09% |
+161,338
| New | +$9.54M |
|
207
lululemon athletica
LULU
$13.5B
| $10.4M | 0.09% |
200,720
-166,498
| -45% | -$11M |
|
208
IPG Photonics
IPGP
$3.61B
| $9.8M | 0.08% |
+81,165
| New | +$9.18M |
|
|
MDCO
209
DELISTED
Medicines Co
MDCO
| $9.49M | 0.08% |
+194,000
| New | +$8.85M |
|
210
Four Corners Property Trust
FCPT
$2.81B
| $9.44M | 0.08% |
413,420
-392,600
| -49% | -$8.43M |
|
211
Cisco
CSCO
$457B
| $9.05M | 0.08% |
267,695
-3,190
| -1% | -$103K |
|
|
TSRO
212
DELISTED
TESARO, Inc.
TSRO
| $8.5M | 0.07% |
+55,263
| New | +$9M |
|
213
Jack Henry & Associates
JKHY
$10.9B
| $8.41M | 0.07% |
90,379
-1,085
| -1% | -$100K |
|
|
ALDR
214
DELISTED
Alder Biopharmaceuticals
ALDR
| $8.27M | 0.07% |
397,350
-965
| -0.2% | -$21.4K |
|
215
Acadia Pharmaceuticals
ACAD
$4.43B
| $8.21M | 0.07% |
+238,694
| New | +$8.43M |
|
216
JPMorgan Chase
JPM
$935B
| $8.06M | 0.07% |
91,740
-1,070
| -1% | -$94.4K |
|
|
LJPC
217
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $8.01M | 0.07% |
+268,290
| New | +$6.85M |
|
218
Verizon
VZ
$195B
| $7.99M | 0.07% |
163,885
+128,560
| +364% | +$6.45M |
|
219
Best Buy
BBY
$18.2B
| $7.22M | 0.06% |
+146,965
| New | +$6.57M |
|
|
SGEN
220
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.06M | 0.06% |
+112,260
| New | +$7.01M |
|
221
Vitamin Cottage Natural Grocers
NGVC
$739M
| $6.76M | 0.06% |
+650,855
| New | +$7.76M |
|
222
Western Digital
WDC
$188B
| $6.27M | 0.05% |
100,455
-278
| -0.3% | -$16K |
|
223
CNO Financial Group
CNO
$5.14B
| $5.8M | 0.05% |
282,995
-1,346,820
| -83% | -$27M |
|
224
Penske Automotive Group
PAG
$14.3B
| $5.79M | 0.05% |
123,705
-1,450
| -1% | -$74.1K |
|
225
Merck
MRK
$322B
| $5.75M | 0.05% |
94,880
+82,137
| +645% | +$4.98M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Westfield Capital Management held 303 positions worth $11.6B, up 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $770M in Q1 2017, closing 45 positions and reducing 133 holdings. Its most notable exit was TJX Companies, an estimated $94.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Westfield Capital Management opened a new position in Biogen worth $98.2M.
- Westfield Capital Management's largest Q1 2017 buy was Biogen: 359,107 shares worth $98.2M.
- Westfield Capital Management added most to Walt Disney in Q1 2017, an estimated $48.8M increase.
- Westfield Capital Management's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $95.4M.
- Westfield Capital Management fully exited TJX Companies in Q1 2017, selling an estimated $94.8M.
- Westfield Capital Management's ten largest holdings make up 17% of its $11.6B portfolio in Q1 2017.
- Westfield Capital Management opened 50 new positions and closed 45 in Q1 2017.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $11.6B.
Based on Westfield Capital Management's 13F filing for Q1 2017, filed 12 May 2017.